Montero-Herradon S, Garcia-Ceca J, Zapata A
Adv Exp Med Biol. 2025; 1471:21-49.
PMID: 40067583
DOI: 10.1007/978-3-031-77921-3_2.
Petazzi P, Ventura T, Luongo F, McClafferty H, May A, Taylor H
Elife. 2024; 13.
PMID: 39714446
PMC: 11666236.
DOI: 10.7554/eLife.94884.
Sturgeon C, Wagenblast E, Izzo F, Papapetrou E
Blood Cancer Discov. 2024; 6(2):94-109.
PMID: 39652739
PMC: 11876951.
DOI: 10.1158/2643-3230.BCD-24-0235.
Nobuhisa I, Melig G, Taga T
Cells. 2024; 13(22).
PMID: 39594589
PMC: 11593047.
DOI: 10.3390/cells13221840.
Haniffa M, Maartens A, Winheim E, Jardine L
Nat Rev Immunol. 2024; .
PMID: 39482372
DOI: 10.1038/s41577-024-01099-1.
Strong capacity of differentiated PD-L1 CAR-modified UCB-CD34 cells and PD-L1 CAR-modified UCB-CD34-derived NK cells in killing target cells and restoration of the anti-tumor function of PD-1-high exhausted T Cells.
Ghaedrahmati F, Akbari V, Seyedhosseini-Ghaheh H, Esmaeil N
Stem Cell Res Ther. 2024; 15(1):257.
PMID: 39135206
PMC: 11321137.
DOI: 10.1186/s13287-024-03871-5.
New insights into the endothelial origin of hematopoietic system inspired by "TIF" approaches.
Hou S, Guo X, Du J, Ding X, Ning X, Wang H
Blood Sci. 2024; 6(4):e00199.
PMID: 39027902
PMC: 11254119.
DOI: 10.1097/BS9.0000000000000199.
The molecular and cellular hematopoietic stem cell specification niche.
Clements W, Khoury H
Exp Hematol. 2024; 136:104280.
PMID: 39009276
PMC: 11338702.
DOI: 10.1016/j.exphem.2024.104280.
Targeting Interactions between Fibroblasts and Macrophages to Treat Cardiac Fibrosis.
Yang B, Qiao Y, Yan D, Meng Q
Cells. 2024; 13(9.
PMID: 38727300
PMC: 11082988.
DOI: 10.3390/cells13090764.
Advances in hematopoietic stem cells ex vivo expansion associated with bone marrow niche.
Deng J, Tan Y, Xu Z, Wang H
Ann Hematol. 2024; 103(12):5035-5057.
PMID: 38684510
DOI: 10.1007/s00277-024-05773-1.
Characterization of gene regulatory networks underlying key properties in human hematopoietic stem cell ontogeny.
Li F, Zhu Y, Wang T, Tang J, Huang Y, Gu J
Cell Regen. 2024; 13(1):9.
PMID: 38630195
PMC: 11024070.
DOI: 10.1186/s13619-024-00192-z.
Single-cell atlas of the small intestine throughout the human lifespan demonstrates unique features of fetal immune cells.
Gu W, Eke C, Santiago E, Olaloye O, Konnikova L
Mucosal Immunol. 2024; 17(4):599-617.
PMID: 38555026
PMC: 11384551.
DOI: 10.1016/j.mucimm.2024.03.011.
A life-time of hematopoietic cell function: ascent, stability, and decline.
Popravko A, Mackintosh L, Dzierzak E
FEBS Lett. 2024; 598(22):2755-2764.
PMID: 38439688
PMC: 11586595.
DOI: 10.1002/1873-3468.14843.
Glycolytic state of aortic endothelium favors hematopoietic transition during the emergence of definitive hematopoiesis.
Pv A, Mehatre S, Verfaillie C, Alam M, Khurana S
Sci Adv. 2024; 10(7):eadh8478.
PMID: 38363844
PMC: 10871539.
DOI: 10.1126/sciadv.adh8478.
Engineered T cells from induced pluripotent stem cells: from research towards clinical implementation.
Netsrithong R, Garcia-Perez L, Themeli M
Front Immunol. 2024; 14:1325209.
PMID: 38283344
PMC: 10811463.
DOI: 10.3389/fimmu.2023.1325209.
Hematopoietic Stem Cell Development in Mammalian Embryos.
Hou S, Liu C, Yao Y, Bai Z, Gong Y, Wang C
Adv Exp Med Biol. 2024; 1442:1-16.
PMID: 38228955
DOI: 10.1007/978-981-99-7471-9_1.
Rapid conversion of porcine pluripotent stem cells into macrophages with chemically defined conditions.
Wu X, Ni Y, Li W, Yang B, Yang X, Zhu Z
J Biol Chem. 2023; 300(1):105556.
PMID: 38097188
PMC: 10825052.
DOI: 10.1016/j.jbc.2023.105556.
Engineering T Cell Development for the Next Generation of Stem Cell-Derived Immunotherapies.
Michaels Y, Durland L, Zandstra P
GEN Biotechnol. 2023; 2(2):106-119.
PMID: 37928777
PMC: 10624212.
DOI: 10.1089/genbio.2023.0008.
Divergent molecular events underlying initial T-cell commitment in human prenatal and postnatal thymus.
He H, Yao Y, Tang L, Li Y, Li Z, Liu B
Front Immunol. 2023; 14:1240859.
PMID: 37828991
PMC: 10565475.
DOI: 10.3389/fimmu.2023.1240859.
Hematopoietic Stem Cell (HSC)-Independent Progenitors Are Susceptible to Mll-Af9-Induced Leukemic Transformation.
Barone C, Orsenigo R, Cazzola A, DErrico E, Patelli A, Quattrini G
Cancers (Basel). 2023; 15(14).
PMID: 37509285
PMC: 10377085.
DOI: 10.3390/cancers15143624.